Glaukos (GKOS) Accumulated Expenses (2014 - 2026)
Glaukos' (GKOS) quarterly Accumulated Expenses came in at $70.3 million in Q1 2026, up 33.31% year-on-year from $52.7 million in Q1 2025, and down 8.34% on a QoQ basis from $76.7 million in Q4 2025.
Glaukos (GKOS) Accumulated Expenses (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Accumulated Expenses data on file, last reported at $70.3 million in Q1 2026.
- On a quarterly basis, Accumulated Expenses rose 33.31% year-over-year to $70.3 million in Q1 2026; TTM through Mar 2026 was $70.3 million, a 33.31% increase from a year earlier, with the FY2025 full-year figure at $76.7 million, up 23.43% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $70.3 million, down from $76.7 million in the prior quarter.
- Over the last five years, Accumulated Expenses for GKOS reached as high as $76.7 million in Q4 2025 and fell as low as $47.6 million in Q1 2022.
- Historically, Accumulated Expenses has averaged $58.8 million across 5 years, with a median of $58.5 million in 2024.
- Across the five-year window, Accumulated Expenses decreased 23.69% in 2022 and jumped 33.31% in 2026, its largest moves.
- Year by year, Accumulated Expenses stood at $58.0 million in 2022, then climbed by 4.52% to $60.6 million in 2023, then gained by 2.52% to $62.1 million in 2024, then gained by 23.43% to $76.7 million in 2025, then retreated by 8.34% to $70.3 million in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $70.3 million in Q1 2026, $76.7 million in Q4 2025, and $67.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.26 Mn |
| Dec 31, 2025 | 76.65 Mn |
| Sep 30, 2025 | 67.63 Mn |
| Jun 30, 2025 | 65.45 Mn |
| Mar 31, 2025 | 52.70 Mn |
| Dec 31, 2024 | 62.10 Mn |
| Sep 30, 2024 | 60.58 Mn |
| Jun 30, 2024 | 58.52 Mn |
| Mar 31, 2024 | 59.49 Mn |
| Dec 31, 2023 | 60.57 Mn |
| Sep 30, 2023 | 56.73 Mn |
| Jun 30, 2023 | 55.32 Mn |
| Mar 31, 2023 | 50.36 Mn |
| Dec 31, 2022 | 57.96 Mn |
| Sep 30, 2022 | 49.15 Mn |
| Jun 30, 2022 | 48.21 Mn |
| Mar 31, 2022 | 47.60 Mn |
| Dec 31, 2021 | 56.03 Mn |
| Sep 30, 2021 | 54.99 Mn |
| Jun 30, 2021 | 63.18 Mn |